Glypican-3与恶性肿瘤的研究及其进展
-
-
[1] PILIA G,HUGHES-BENZIE RM,MACKENZIE A,et al.Mutations in GPC3,a glypican gene,cause the Simpson-Golabi-Behmel overgrowth syndrome[J].Nat Genet,1996,12(3):241. [2] CAT DB,DAVID G.Developmental roles of the glypicans[J].Semin Cell Dev Biol,2001,12(2):117. [3] VEUQELERS M,VERMEESCH J,REEKMANS G,et al.Characterization of glypican-5 and chromosomal localization of human GPC5,a new member of the glypican gene family[J].Genomics,1997,40(1):24. [4] HSU HC,CHENG W,LAI PL.Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma:biological significance and temporospatial distribution[J].Cancer Res,1997,57(22):5179. [5] FILMUS J,CAPURRO M.The role of glypican-3 in the regulation of body size and cancer[J].Cell Cycle,2008,7(18):2787. [6] LAQANA SM,SALOMAO M,BAO F,et al.Utility of an immunohistochemical panel consisting of glypican-3,heat-shock protein-70,and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma[J].Appl Immunohistochem Mol Morphol,2013,21(2):170. [7] YAO M,YAO DF,BIAN YZ,et al.Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma[J].Hepatobiliary Pancreat Dis Int,2013,12(2):171. [8] SHIRAKAWA H,SUZUKI H,SHIMOMURA M,et al.Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma[J].Cancer Sci,2009,100(8):1403. [9] HIPPO Y,WATANABE K,WATANABE A,et al.Identification of soluble NH2-terminal fragment of glypican3 as a serological marker for early-stage hepatocellular carcinoma[J].Cancer Res,2004,64(7):2418. [10] 杨华瑜,王绎忱,徐海峰,等.血清AFP、GP73、GPC3单独及联合检测对肝细胞癌的诊断价值[J].癌症进展,2013,11(3):249. [11] 许方,李晓兰,王玉梅,等.GPC3对原发性肝癌的诊断价值[J].大连医科大学学报,2013,35(4):381. [12] LEE HJ,YEON JE,SUH SJ,et al.Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma[J].Gut Liver,2014,8(2):177. [13] WANG HL,ANATELLI F,ZHAI QJ,et al.Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions[J].Arch Pathol Lab Med,2008,132(11):1723. [14] KANDIL D,LEIMAN G,ALLEQRETTA M,et al.Glypican-3 immunocytochemistry in liver fine-needle aspirates:a novol stain to assist in the differentiation of benign and malignant liver lesions[J].Cancer,2007,111(5):316. [15] 王付强,景志亮,王志静,等.肿瘤组织中GPC3、Hepatocyte、CD34检测对AFP阴性肝细胞癌的辅助诊断作用[J].山东医药,2014,54(11):19. [16] WEI-KAI XIAO,CHAO-YING QI,DONG CHEN,et al.Prognostic significance of glypican-3 in hepatocellular carcinoma:a meta-analysis[J].BMC Cancer,2014,14(1):104. [17] 李海荣,黄兰姗,陈罡,等.GPC3与肝癌细胞增殖的相关性[J].世界华人消化杂志,2014,22(15):2108. [18] 钟鼎文,邹书兵,谢元才,等.GPC3在原发性肝细胞癌中的表达及其临床病理相关性研究[J].湖北民族学院学报(医学版),2013,30(4):4. [19] LIBBRECHT L,SEVERI T,CASSIMAN D,et al.Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis,dysplastic nodules and focal nodular hyperplasia-like nodules[J].Am J Surg Pathol,2006,30(11):1405. [20] 杜经丽,韦立新,王玉兰.磷脂酰肌醇蛋白聚糖3等抗体在高分化肝细胞癌中的表达及其鉴别诊断意义[J].中华病理学杂志,2011,40(1):11. [21] 叶玉清,王凤华,黄香婷,等.磷脂酰肌醇蛋白聚糖-3的表达在肝细胞癌中的意义[J].中华病理学杂志,2011,40(9):626. [22] 尹寿新,马美雪,周震,等.GPC3通过活化Wnt/β-catenin通路促进HepG2生长[J].胃肠病学和肝病学杂志,2015,24(11):1357. [23] 蔚丹丹,姚敏,陈洁,等.磷脂酰肌醇蛋白聚糖3转录干预对肝癌细胞侵袭和血管新生的抑制作用[J].中华肝脏病杂志,2013,21(6):452. [24] MIDORIKAWA Y,ISHIKAWA S,IWANARI H,et al.Glypican-3,overexpressed in hepatocellular carcinoma,modulates FGF2 and BMP-7 signaling[J].Int J Cancer,2003,103(4):455. [25] KITTAKA N,TAKEMASA I,TAKEDA Y,et al.Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data[J].Eur J Cancer,2008,44(6):885. [26] QIU LW,YAO DF,ZONG L,et al.Abnormal expression of insulin-like growth factor-Ⅱ and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development[J].Hepatobiliary Pancreat Dis Int,2008,7(4):406. [27] CHENG WT,XU K,TIAN DY,et al.Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells[J].Int J Oncol,2009,34(3):829. [28] 王莉,惠宁,满晓波,等.GPC3在卵巢癌中的表达及其临床意义[J].解放军医学杂志,2007,32(10):1017. [29] 李雪洁,李红霞,李霄,等.GPC3在卵巢透明细胞腺癌中的表达及临床意义[J].南京医科大学学报(自然科学版),2015,35(5):631. [30] MAEDA D,OTA S,TAKAZAWA Y,et al.Glypican-3 expression in clear cell adenocarcinoma of the ovary[J].Mod Pathol,2009,22(6):824. [31] STADLMANN S,GUETH U,BAUMHOER D,et al.Glypican-3 expression in primary and recurrent ovarian carcinomas[J].Int J Gynecol Pathol,2007,26(3):341. [32] 袁东红,谢华红,王燕,等.磷脂酰肌醇蛋白聚糖3在人大肠癌组织中的表达[J].中华医学杂志,2008,88(22):1540. [33] JOO EJ,WEYERS A,LI G,et al.Carbohydrate-containing molecules as potential biomarkers in colon cancer[J].OMICS,2014,18(4):231. [34] 苏宁,郑大勇,陈斌,等.应用组织芯片技术检测GPC3蛋白在肝细胞癌及其他肿瘤中的表达[J].广东医学,2009,30(9):1312. [35] 李慧灵,邓秋华,黄丽燕,等.磷脂酰肌醇蛋白聚糖-3在肺鳞癌和腺癌中的不同表达及其与预后的关系[J].南方医科大学学报,2013,33(2):212. [36] AVIEL-RONEN S,LAU SK,PINTILIE M,et al.Glypican-3 is overexpressed in lung squamous cell carcinoma,but not in adenocarcinoma[J].Mod Pathol,2008,21(7):817. [37] KOMORI H,BEPPU T,BABA H,et al.Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma[J].Nihon Rinsho,2010,68(Suppl 7):833. [38] YAMANAKA K,ITO Y,OKUYAMA N,et al.Immunohistochemical study of glypican 3 in thyroid cancer[J].Oncology,2007,73(5/6):389. [39] 吕龙,陈功.GPC3在人胃癌中的表达及促瘤机制初探[J].现代肿瘤医学,2015,23(5):620. [40] 程春红,王芳,邵剑波,等.Glypican-3蛋白在儿童肾母细胞瘤中的表达及其与MSCT征象关系研究[J].临床医学工程,2014,21(9):1099. [41] 张春芳,齐冬雪,杨聪颖,等.SALL4、D2-40和Glypican-3在睾丸生殖细胞肿瘤诊断中的应用[J].临床与实验病理学杂志,2015,31(8):850. [42] VALSECHI MC,OLIVEIRA AB,CONCEICAO AL,et al.GPC3 reduces cell proliferation in renal carcinoma cell lines[J].BMC Cancer,2014,14(1):631. [43] FENG M,HO M.Glypican-3 antibodies:a new therapeutic target for liver cancer[J].FEBS Lett,2014,588(2):377. [44] IKEDA M,OHKAWA S,OKUSAKA T,et al.Japanese phase Ⅰ study of GC33,a humanized antibody against glypican-3 for advanced hepatocellular carcinoma[J].Cancer Sci,2014,105(4):455. [45] 王玉亮,刘涛,穆红.癌胚抗原磷脂酰肌醇蛋白聚糖3单克隆抗体的制备及应用[J].天津医药,2014,42(3):235. [46] 马艳,金小宝,李小波,等.可溶性GPC3基因的克隆及酵母表达[J].广东药学院学报,2014,30(3):358. [47] HUIPING GAO,KESANG LI,HONG TU,et al.Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma[J].Clin Cancer Res,2014,20(24):6418. [48] SUZUKI S,SHIBATA K,KIKKAWA F,et al.Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy:two case reports[J].Hum Vaccin Immunother,2014,10(2):338.
点击查看大图
计量
- 文章访问数: 4049
- HTML全文浏览量: 464
- PDF下载量: 130
- 被引次数: 0